Pharmafile Logo

Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia

December 1, 2025 |  

- PMLiVE

For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the first and only medical-grade Generative AI experience that integrates Medscape’s proprietary content, peer-reviewed literature, and real-time medical news to deliver timely, trustworthy, specialty-specific insights that support informed decision-making.

Medscape AI marks a transformation from a single search tool to a robust platform of integrated AI-powered solutions for HCPs. This shift emphasizes integration, bringing together multiple AI capabilities designed to support clinicians in all aspects of their practice, beyond just search, making the evolution substantial and future-oriented with exciting developments to come. 

Among the proven benefits of Medscape AI:

  • Reliability: Clinically Vetted Sources, Transparent By Design
    • Built on both Medscape’s trusted proprietary content and evidence from 400+ of the most prestigious peer-reviewed journals across a wide range of specialties — spanning oncology, cardiology, dermatology, internal medicine, and beyond — with no unverified material from the open internet
    • AI responses are traceable, transparent, and supported by citations 
  • Recency: Always Current and Continuously Updated
    • Integrates verified real-time news, research updates, and guideline changes
    • Daily and weekly editorial oversight ensures outputs reflect the latest evidence 
  • Relevance: Aligned to Practice and Patient Care
    • Jointly built with practicing clinicians to bridge the gap between AI innovations and clinical reality
    • Synthesized insights tuned to each specialty, workflow, and clinical context
    • Guidance supports differential diagnosis, treatment decisions, and next-step care
    • Integrated across the Medscape experience, including the industry-leading Medscape newsreader and point-of-care decision support tools  
  • Time-Saving Clinical Efficiency
    • Digestible, actionable responses free up clinicians to focus more on patient care and less time searching and reviewing literature

“As AI becomes essential to modern clinical practice, it not only needs to unlock unmatched value to our users, it must also meet the rigorous standards clinicians require: accurate, current, and evidence-based,” said Bob Brisco, CEO of Medscape’s parent company, Internet Brands. “Medscape AI delivers this and more. It cuts through the information overload plaguing healthcare professionals, synthesizing evidence instantly to drive better patient outcomes. It’s clinical precision in your pocket – expert guidance that’s tailored to meet your exact query, grounded in evidence, and powered by Medscape’s human-validated compendium of medical expertise.”

Medscape  is advancing medical education through data-driven insights and innovative technology . Focused on the oncology and hematology community at ASH 2025, Medscape Education delivers transformative CME solutions that go beyond knowledge transfer to impact real-world clinical behavior, and, most critically, patient outcomes. Between 2023 and 2025 Medscape’s learning design and scientific content teams have delivered 102 programs in hematology, reaching 836,531 learners, who are potentially impacting over 3 million patients per month. 

 Visit booth #443 to explore our comprehensive hematology education offerings and get hands-on experience with the new Medscape AI feature!

Educational Symposia

Join us on Friday, December 5, 2025 for 5 Medscape Oncology educational symposia designed to help clinicians translate the latest clinical data into practice. Register here.

  • Rare Clinical Spotlight: Exploring Castleman Disease, Cold Agglutinin Disease and Acute Intermittent Porphyria
    • Time: 11:30 AM – 1:00 PM ET
    •  Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
    • Room: Plaza International HIJK
  • Targeted Therapies in R/R PCNSL: New Frontiers in Treatment and Management
    • Time: 11:30 AM – 1:00 PM ET
    • Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
    • Room: Plaza International DEFG 
  • Tailoring Bispecific Antibodies to Individualize R/R Follicular Lymphoma Care: A Case-Based Discussion
    • Time: 11:30 AM – 1:00 PM ET
    •  Orange County Convention Center, 9800 International Drive, Orlando, FL, 32819
    • Room: W311 EFGH
  • Personalizing Relapsed/Refractory DLBCL With Bispecific Antibody Therapy: A Case-Based Discussion
    • Time: 3:30 PM – 5:00 PM ET
    •  Orange County Convention Center, 9800 International Drive, Orlando, FL, 32819
    • Room: W311 EFGH
  • Acute Hepatic Porphyria: Bridging Gaps for Better Diagnosis and Management
    • Time: 3:30 PM – 5:00 PM ET
    • Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
    • Room: Plaza International HIJK

ASH Abstract Publication 

Michelle Worst, PharmD, BCOP, MBA, CHCP has an online abstract accepted at ASH 2025. The abstract, titled “Assessing the influence of live and online enduring CME activities presented at the 66th ASH annual meeting on hematology/oncology specialists using pre-/post-education evaluations,” will be published online-only on the ASH abstracts site in the November supplemental issue of Blood

For more information, please contact Jelena Spyropoulos.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Medscape Oncology to Make a Significant Impact at ASCO 2024

ASCO is one of the biggest conferences of the year for Medscape Oncology, and the team is ready to make an impact in Chicago. They’ll be manning booth #26030, where...

Medscape Oncology Launches Inaugural Medscape Fellows Program at ASCO 2024

Medscape Oncology is excited to announce the launch of the first-ever Medscape Fellows Program at the 2024 ASCO meeting in Chicago, Illinois. This groundbreaking program aims to nurture young oncology...

Navigating Food Allergy Management: Trends, Treatments, and Decision-Making

Are you having trouble navigating the management of food allergies? Join our faculty experts for a live conversation on social media to learn about the evolving complexities in food allergy...

The Power of Patient Insights to Improve Cancer Care

Two global patient advocacy groups—The Lymphoma Coalition and Lung Cancer Europe— are compiling data from their communities on the real-world experience of living with cancer. What the data reveals sometimes...

Medscape Education Continues Its Patient-Centric Mission at EHA 2024

Anticipation is building at Medscape Education as the team prepares for the EHA 2024 Congress. Medscape Education is excited to announce a significant presence during the congress including a Medscape...

Getting in-sync with Public Health at SYNC 2024

Medscape Education is bringing its public health efforts to Washington, DC for the SYNC conference on HIV, HCV, STIs, Harm Reduction, and LGBTQ health. During the conference, Lindsey will present...

Medscape Education and KDIGO Nephrology Collaboration Accelerates Improvements to Patient Care

Ahead of the 61st European Renal Association (ERA) Congress, Medscape Education and KDIGO (Kidney Disease: Improving Global Outcomes) announce an educational collaboration through a series of webinars to improve anemia-related...

Medscape Brings Impact and Data to ESPGHAN

The ESPGHAN Congress in Milan was full of impact as Medscape Education Global presented 5 scientific posters examining the outcomes of their education. The posters detailed the impact Medscape Education...

Empowering Nurses Through Education

Nurse education is powerful and makes an impact.

Pioneering Paths: Women Leadership in Rare Disease

Rare diseases are often thought of as affecting one in 100,000 or one in 1,000,000 people, and that is true for some conditions. But there are many rare diseases that...